AGT Back

angiotensinogen (serpin peptidase inhibitor, clade A, member 8)

External References:      Wikipedia GeneCards HUGO COSMIC Google Scholar

NCBI Description of AGT

The protein encoded by this gene, pre-angiotensinogen or angiotensinogen precursor, is expressed in the liver and is cleaved by the enzyme renin in response to lowered blood pressure. The resulting product, angiotensin I, is then cleaved by angiotensin converting enzyme (ACE) to generate the physiologically active enzyme angiotensin II. The protein is involved in maintaining blood pressure and in the pathogenesis of essential hypertension and preeclampsia. Mutations in this gene are associated with susceptibility to essential hypertension, and can cause renal tubular dysgenesis, a severe disorder of renal tubular development. Defects in this gene have also been associated with non-familial structural atrial fibrillation, and inflammatory bowel disease.

Community Annotation of AGT Add / Edit AGT: Annotations

No community annotations yet for AGT.
Sort mutations by: Tumor type  Mutation type  Position  
Straightedge cursor Expand

Figure notes


• "Mouse over" a mutation to see details.
• Missense green saturation indicates evolutionary conservation of the mutated positions.
• Red hashes in protein strip are splice sites.
• Blue-white-red bars are log2 copy ratio distributions (–1 to +1) from Zack et al. (2013).


Legend

AGT is highly significantly mutated in
(none)
AGT is significantly mutated in
(none)
AGT is near significance in
(none)

Click on a tumor type to see its full list of significant genes.

Data details


Mutation list for AGT